Umecrine Cognition AB
556698-3655ActiveDeveloping novel drugs for neurological disorders caused by neuroinflammation.
Overview
- 1–4
- Employees
- ≤1K SEK
- Revenue
- 2006
- Founded
Key Decision Makers
Viktor Drvota
CEO
Magnus Doverskog
Chief Executive Officer
Pernilla Sandwall
COO (Chief Operating Officer)
Thomas P. Blackburn
Non-executive Director
+6 more contacts in Funnelfeedr
Description
Umecrine Cognition AB is a biotechnology company focused on developing novel treatments for neurological disorders in the brain. Their primary scientific focus is on GABAA receptor modulating steroid antagonists. They aim to treat cognitive disorders caused by neuroinflammation resulting from a wide...
Tags
Keywords
Company Information
- Industry
- Tillverkning av läkemedel
- Legal Form
- Aktiebolag
- VAT Number
- SE556698365501
Decision Makers
10 contacts in FunnelfeedrViktor Drvota
CEO
Magnus Doverskog
Chief Executive Officer
Pernilla Sandwall
COO (Chief Operating Officer)
Thomas P. Blackburn
Non-executive Director
Bruce F. Scharschmidt
Non-executive Director
Torbjörn Bäckström
Chief Science Officer
Hans Christopher Toll
Chief Financial Officer
John Öhd
Non-executive Director
Anders Bladh
Non-executive Director
Roberto Camerini
Medical Director
Similar Companies
20 similar companies in FunnelfeedrAlzeCure Pharma AB
10–19 employeesSwedish pharma developing CNS drugs for Alzheimer's and pain.
LobSor Pharmaceuticals Aktiebolag
1–4 employeesDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Grespo AB
0 employeesYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Gabather AB
1–4 employeesDeveloping next-generation CNS therapeutics to restore brain balance.
ScandiBio Therapeutics AB
0 employeesAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Browse More
Umecrine Cognition AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo